CoChat

Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease

Open access
Watfa, G., Dragonas, C., Brosche, T., Dittrich, R., Sieber, C.C., Alecu, C., Benetos, Athanase, Nzietchueng, R. · 2011 · The Journal of nutrition, health and aging
Cited by 70

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Many studies have shown that short telomere length (TL) is associated with high oxidative stress and various age-related diseases. Parkinson's disease (PD) is an age-related disease, and although its pathogenic mechanism is uncertain, oxidative stress is believed to be implicated in this pathology. The aim of this case-control study was to assess both TL and the different markers of oxidative stress in elderly patients with PD compared to age control subjects. METHODS: 20 PD patients and 15 age-matched controls, >65 years were studied. TL was measured by Southern blotting from DNA samples extracted from white blood cells. Superoxide dismutase (SOD) activity and plasma levels of total glutathione and protein carbonyls were determined. RESULTS: There was a trend for lower TL in PD patients: 6.06 ± 0.81 kb in PD versus 6.45 ± 0.73 kb in controls (p = 0.08). No significant difference was found between the two groups in terms of oxidative stress markers. In controls, age was the main determinant of telomere shortening (r = -0.547; p = 0.03) whereas, in PD patients, telomere shortening was mainly dependent on plasmatic concentrations of carbonyl proteins (r= -0.544; p=0.044). In PD patients, a negative association was observed between plasma carbonyl protein levels and SOD activity (r= -0.622, p=0.004). CONCLUSIONS: In PD, TL is shorter in presence of high oxidative stress as measured by carbonyl protein levels. The absence of telomere attrition with age among patients with PD could reflect a telomere regulation by mechanisms other than age.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12603-010-0275-7

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 27

  1. Cattan, 2008, Chronic oxidative stress induces a tissuespecific reduction in telomere length in CAST/Ei mice, Free Radic Biol Med, 44, 1592, 10.1016/j.freeradbiomed.2008.01.007 · DOI
  2. Chang, 1995, Telomere length and replicative aging in human vascular tissues, Proc Natl Acad Sci U S A, 92, 11190, 10.1073/pnas.92.24.11190 · DOI · Paper page
  3. Benetos, 2001, Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity, Hypertension, 37, 381, 10.1161/01.HYP.37.2.381 · DOI · Paper page
  4. Jeanclos, 2000, Telomere length inversely correlates with pulse pressure and is highly familial, Hypertension, 36, 195, 10.1161/01.HYP.36.2.195 · DOI · Paper page
  5. Panossian, 2003, Telomere shortening in T cells correlates with Alzheimer's disease status, Neurobiol Aging, 24, 77, 10.1016/S0197-4580(02)00043-X · DOI · Paper page
  6. Dexter, 1994, Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study, Mov Disord, 9, 92, 10.1002/mds.870090115 · DOI · Paper page
  7. Wang, 2008, Telomere length and risk of Parkinson's disease, Mov Disord, 23, 302, 10.1002/mds.21867 · DOI · Paper page
  8. Guan, 2008, A percentage analysis of the telomere length in Parkinson's disease patients, J Gerontol A Biol Sci Med Sci, 63, 467, 10.1093/gerona/63.5.467 · DOI · Paper page
  9. Dragonas, 2009, Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease, Clin Chem Lab Med, 47, 894, 10.1515/CCLM.2009.205 · DOI · Paper page
  10. Ershler, 2001, The value of the SENIEUR protocol: distinction between “ideal aging” and clinical reality, Mech Ageing Dev, 122, 134, 10.1016/S0047-6374(00)00241-4 · DOI
  11. Miller, 1988, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res, 16, 1215, 10.1093/nar/16.3.1215 · DOI · Paper page
  12. Tentolouris, 2007, White blood cells telomere length is shorter in males with type 2 diabetes and microalbuminuria, Diabetes Care, 30, 2909, 10.2337/dc07-0633 · DOI
  13. Martin-Ruiz, 2006, Telomere length predicts poststroke mortality, dementia, and cognitive decline, Ann Neurol, 60, 174, 10.1002/ana.20869 · DOI · Paper page
  14. Lev, 2003, Apoptosis and Parkinson's disease, Prog Neuropsychopharmacol Biol Psychiatry, 27, 245, 10.1016/S0278-5846(03)00019-8 · DOI · Paper page
  15. Nawrot, 2004, Telomere length and possible link to X chromosome, Lancet, 363, 507, 10.1016/S0140-6736(04)15535-9 · DOI · Paper page
  16. Prigione, 2006, Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage, Neurobiol Dis, 23, 36, 10.1016/j.nbd.2006.01.013 · DOI
  17. Prigione, 2009, Increased oxidative stress in lymphocytes from untreated Parkinson's disease patients, Parkinsonism Relat Disord, 15, 327, 10.1016/j.parkreldis.2008.05.013 · DOI
  18. Serra, 2001, Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients, J Neural Transm, 108, 1135, 10.1007/s007020170003 · DOI
  19. Younes-Mhenni, 2007, Peripheral blood markers of oxidative stress in Parkinson's disease, Eur Neurol, 58, 78, 10.1159/000103641 · DOI
  20. Martin, 2009, Glutathione—a review on its role and significance in Parkinson's disease, FASEB J, 23, 3263, 10.1096/fj.08-125443 · DOI · Paper page
  21. Alam, 1997, A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease, J Neurochem, 69, 1326, 10.1046/j.1471-4159.1997.69031326.x · DOI · Paper page
  22. Sudha, 2003, Free radical toxicity and antioxidants in Parkinson's disease, Neurol India, 51, 60
  23. Kocaturk, 2000, Superoxide dismutase activity and zinc and copper concentrations in Parkinson's disease, Pathophysiology, 7, 63, 10.1016/S0928-4680(00)00030-4 · DOI
  24. Abraham, 2005, Erythrocyte antioxidant enzymes in Parkinson's disease, Indian J Med Res, 121, 111
  25. Bostantjopoulou, 1997, Superoxide dismutase activity in early and advanced Parkinson's disease, Funct Neurol, 12, 63
  26. Ihara, 1999, Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data, J Neurol Sci, 170, 90, 10.1016/S0022-510X(99)00192-6 · DOI
  27. De Meyer, 2008, Studying telomeres in a longitudinal population based study, Front Biosci, 13, 2960, 10.2741/2901 · DOI · Paper page

Cited by

See all 70

Metadata

Authors
Watfa, G., Dragonas, C., Brosche, T., Dittrich, R., Sieber, C. C., Alecu, C., Benetos, A., & Nzietchueng, R.
Venue
The Journal of nutrition, health and aging
Publisher
Elsevier BV
Published
2011-04
Volume
15
Issue
4
Pages
277-281
ISSN
1279-7707 (ISSN-L)
OpenAlex
W2021667351
Cited by
70
References
9
FWCI
2.43
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease. https://app.cochat.ai/papers/10.1007/s12603-010-0275-7
The paper
Watfa, G., Dragonas, C., Brosche, T., Dittrich, R., Sieber, C. C., Alecu, C., Benetos, A., & Nzietchueng, R. (2011). Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease. The Journal of nutrition, health and aging. https://doi.org/10.1007/s12603-010-0275-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.